Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection
Clinical trial NCT03656510 · TERMINATED
Trial details
- NCT number
- NCT03656510
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-29
- Primary completion
- 2022-04-18
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.